Central Valley Hospice Palliative Medicine – Trademark Portfolio

Entity Type: 03

Central Valley Hospice Palliative Medicine holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include SOMETIMES CURE, OFTEN TREAT, ALWAYS CARE. The owner is based in Tulare, CA.

Tulare, CA 93274

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Central Valley Hospice Palliative Medicine's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Central Valley Hospice Palliative Medicine have?

Central Valley Hospice Palliative Medicine has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Central Valley Hospice Palliative Medicine file in?

Central Valley Hospice Palliative Medicine files trademarks across 1 Nice Classification class. The most active classes are Class 44 (Medical Services). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What are Central Valley Hospice Palliative Medicine's most well-known trademarks?

Central Valley Hospice Palliative Medicine's registered trademark portfolio includes well-known marks such as SOMETIMES CURE, OFTEN TREAT, ALWAYS CARE. These are among 1 currently registered trademark in the portfolio.

What is Central Valley Hospice Palliative Medicine's trademark registration success rate?

Central Valley Hospice Palliative Medicine has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.